Jim Simons Sqz Biotechnologies CO Transaction History

Renaissance Technologies LLC

  • $63.1 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023
BUY
$0.27 - $0.68 $2,511 - $6,324
9,300 Added 12.52%
83,603 $23,000
Q1 2023

May 12, 2023
SELL
$0.53 - $0.87 $21,054 - $34,560
-39,725 Reduced 34.84%
74,303 $42,000
Q4 2022

Feb 13, 2023
BUY
$0.67 - $2.85 $37,134 - $157,961
55,425 Added 94.58%
114,028 $84,000
Q3 2022

Nov 14, 2022
BUY
$2.16 - $3.48 $1,512 - $2,436
700 Added 1.21%
58,603 $134,000
Q2 2022

Aug 12, 2022
BUY
$2.77 - $5.0 $160,391 - $289,515
57,903 New
57,903 $184,000

Others Institutions Holding SQZ

# of Institutions
3
Shares Held
1.47M
Call Options Held
0
Put Options Held
0
View Full List

About SQZ Biotechnologies Co

SQZ Quotes by TradingView
  • Ticker SQZ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,248,600
  • Market Cap $1.46M
  • Description
  • SQZ Biotechnologies Company, a clinical-stage biotechnology company, develops cell therapies for patients with cancer, autoimmune, infectious diseases, and other serious conditions. Its lead product candidate is SQZ-PBMC-HPV, from its SQZ Antigen Presenting Cells platform, which is in a Phase I clinical trial as a monotherapy and in combination ...
More about SQZ
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email